{"id":2812,"date":"2021-07-21T14:00:27","date_gmt":"2021-07-21T14:00:27","guid":{"rendered":"https:\/\/regensight.com\/portfolio\/ritsight\/"},"modified":"2025-12-15T11:03:14","modified_gmt":"2025-12-15T11:03:14","slug":"ritsight","status":"publish","type":"portfolio","link":"https:\/\/regensight.com\/en\/portfolio\/ritsight\/","title":{"rendered":"RitSight"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t
\n

<\/h2>

Ophthalmic solution with high riboflavin concentration <\/span><\/h2>
<\/div>

RitSight is a 0.22% riboflavin formulation manufactured with an innovative process to offer the eye surgeon a unique, very high quality, safe and effective product for all available corneal cross-linking protocols<\/p><\/div><\/div>\n <\/section>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\"RitSight<\/figure><\/div>
\"RitSight<\/figure><\/div>\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t<\/i>\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\t\t\t\t\t\t<\/i>\t\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t

Indications<\/h4>

Ritsight <\/strong>is a class IIb medical device for the indication of use to protect the inner ocular structures from the excessive exposure of UV-A light radiation during the corneal cross-linking procedure for the treatment of keratoconus, iatrogenic corneal ectasia, bullous keratopathy and keratitis.<\/p>

The medical device can be applied on the cornea manually in either epi-off<\/strong> or epi-on<\/strong> corneal cross-linking protocols and via controlled corneal iontophoresis<\/strong>.<\/p>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t

Technical Features<\/strong><\/h4>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
    \n\t\t\t\t\t\t\t
  • \n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t<\/i>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t3-years expire date. Storage at room temperature (4\u00b0 - 25\u00b0 C)<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t
  • \n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t<\/i>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\tUnique formulation for EpiOFF and EpiON CXL protocols<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t
  • \n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t<\/i>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\tPackaging with Data Matrix Code for UV-A devices with integrated digital traceability<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t
    \n\t\t\t\t

    Mode of use
    <\/strong><\/h4>

    RitSight<\/strong> can be used either for epi-off (i.e., with epithelial removal) or epi-on (or transepithelial) corneal cross-linking protocols.
    RitSight is instilled directly onto the cornea. A drop can be applied 3 times per minute onto to the cornea for at least 10 minutes before UV-A irradiation.
    The UV-A irradiation must follow only after adequate imbibition of the cornea with RitSight<\/strong>. The UV-A irradiation power or the emitted UV-A energy dose must not exceed 40 mW\/cm2<\/sup> or 10 J\/cm2<\/sup> respectively. It is recommended to use a theranostic UV medical device<\/strong> estimating the corneal riboflavin concentration and the emitted UV energy dose.<\/p>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

    \n\t\t\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t
    \n

    <\/h2>

    Advantages<\/span><\/h2>

    3 ml volume<\/h4><\/div><\/div>\n <\/section>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t
    \n\t\t\t\t

    Protocollo CXL EpiOFF:
    <\/span> <\/strong>
    decreases the soaking
    time improving
    treatment safety and efficacy<\/p>\n

    EpiON CXL protocol:
    <\/strong><\/span>improves tratment efficacy thanks to greater stromal penetration through the intact epithelium. It is specifically designed for corneal iontophoresis delivery<\/p>\n

    Thin keratoconus corneas:
    <\/strong><\/span>Indicated for treating very thin corneas (370 \u00b5m)<\/p>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

    \n\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t\t\t\t\"logo_RS\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t
    \n\t\t\t\t

    RitSight is not part of the C4V CHROMO4VIS medical device.<\/strong><\/em><\/span><\/h4>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

    Ophthalmic solution with high riboflavin concentration RitSight is a 0.22% riboflavin formulation manufactured with an innovative process to offer the eye surgeon a unique, very high quality, safe and effective product for all available corneal cross-linking protocols Indications Ritsight is a class IIb medical device for the indication of use to protect the inner ocular […]<\/p>\n","protected":false},"featured_media":2818,"menu_order":0,"template":"elementor_theme","meta":{"cybocfi_hide_featured_image":""},"portfolio-cat":[65],"portfolio-tag":[66],"portfolio-filter":[5],"_links":{"self":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/portfolio\/2812"}],"collection":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/portfolio"}],"about":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/types\/portfolio"}],"version-history":[{"count":28,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/portfolio\/2812\/revisions"}],"predecessor-version":[{"id":5768,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/portfolio\/2812\/revisions\/5768"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/media\/2818"}],"wp:attachment":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/media?parent=2812"}],"wp:term":[{"taxonomy":"portfolio-cat","embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/portfolio-cat?post=2812"},{"taxonomy":"portfolio-tag","embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/portfolio-tag?post=2812"},{"taxonomy":"portfolio-filter","embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/portfolio-filter?post=2812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}